| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 3.827 | 6.149 | 5.275 | 4.167 | 8.157 | 14.113 | 849 | 15.459 |
| Total Income - EUR | - | - | 3.827 | 6.149 | 5.275 | 4.167 | 8.157 | 14.113 | 849 | 15.459 |
| Total Expenses - EUR | - | - | 1.234 | 3.425 | 3.858 | 2.186 | 2.610 | 1.749 | 1.040 | 1.100 |
| Gross Profit/Loss - EUR | - | - | 2.593 | 2.724 | 1.417 | 1.981 | 5.547 | 12.364 | -191 | 14.359 |
| Net Profit/Loss - EUR | - | - | 2.483 | 2.540 | 1.257 | 1.897 | 5.430 | 11.949 | -249 | 12.108 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Ely Cor Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 623 | 495 | 2.105 | 2.443 | 1.577 | 1.995 | 1.182 | 655 |
| Current Assets | - | - | 2.145 | 1.854 | 1.515 | 2.905 | 4.131 | 12.828 | 1.138 | 12.275 |
| Inventories | - | - | 331 | 106 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 438 | 430 | 0 | 692 | 283 | 11.691 | 0 | 11.065 |
| Cash | - | - | 1.377 | 1.318 | 1.515 | 2.212 | 3.848 | 1.137 | 1.138 | 1.210 |
| Shareholders Funds | - | - | 2.526 | 291 | 1.300 | 1.938 | 5.470 | 11.990 | 403 | 12.148 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 241 | 2.494 | 2.320 | 3.409 | 237 | 2.833 | 1.917 | 782 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ely Cor Med Srl